Medipal Holdings (TSE:7459) EBIT per Share : 円353.13 (TTM As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Medipal Holdings EBIT per Share?

Medipal Holdings's EBIT per Share for the three months ended in Dec. 2023 was 円99.07. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円353.13.

During the past 12 months, the average EBIT per Share Growth Rate of Medipal Holdings was -1.10% per year. During the past 3 years, the average EBIT per Share Growth Rate was 9.10% per year. During the past 5 years, the average EBIT per Share Growth Rate was 1.20% per year. During the past 10 years, the average EBIT per Share Growth Rate was 3.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Medipal Holdings's EBIT per Share or its related term are showing as below:

TSE:7459' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -27.1 Med: -0.8 Max: 17.7
Current: 9.1

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Medipal Holdings was 17.70% per year. The lowest was -27.10% per year. And the median was -0.80% per year.

TSE:7459's 3-Year EBIT Growth Rate is ranked better than
53.16% of 79 companies
in the Medical Distribution industry
Industry Median: 7.7 vs TSE:7459: 9.10

Medipal Holdings's EBIT for the three months ended in Dec. 2023 was 円20,887 Mil.

Medipal Holdings EBIT per Share Historical Data

The historical data trend for Medipal Holdings's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipal Holdings EBIT per Share Chart

Medipal Holdings Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT per Share

Get a 7-Day Free Trial

329.51

220.01

255.92

323.54

352.95

Medipal Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															63.79	93.37	60.62	99.07	100.07

Medipal Holdings EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Medipal Holdings's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	74749	/	211.786
=	352.95

Medipal Holdings's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	20887	/	210.827
=	99.07

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円353.13

Medipal Holdings (TSE:7459) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Medipal Holdings EBIT per Share Related Terms

Thank you for viewing the detailed overview of Medipal Holdings's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Medipal Holdings (TSE:7459) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medipal Holdings Corp (TSE:7459) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

MEPDF:USA MAHLY:USA 59Z:Germany

Address

2-7-15, Yaesu, Chuo-ku, Tokyo, JPN, 104-8461

Website

http://www.medipal.co.jp

Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.

Medipal Holdings (TSE:7459) Headlines

No Headlines